A switch in pathogenic mechanism in myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis in IFN-γ-inducible lysosomal thiol reductase-free mice

Journal of Immunology

Volumn 188, Issue 12, 2012, Pages 6001-6009

  Bergman, Cheryl M ^a   Marta, Cecilia B ^b,d   Maric, Maja ^c   Pfeiffer, Steven E ^b   Cresswell, Peter ^a   Ruddle, Nancy H ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^d SANOFI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON INDUCIBLE LYSOSOMAL THIOL REDUCTASE; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; OXIDOREDUCTASE; UNCLASSIFIED DRUG;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; DISULFIDE BOND; FEMALE; HISTOPATHOLOGY; IMMUNIZATION; IMMUNOFLUORESCENCE; IMMUNOGENICITY; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; OLIGODENDROGLIA; PATHOGENESIS; PLASMA CELL; PRIORITY JOURNAL; WILD TYPE;

AMINO ACID SEQUENCE; ANIMALS; ANTIGEN-PRESENTING CELLS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FLUORESCENT ANTIBODY TECHNIQUE; GLYCOPROTEINS; HUMANS; IMMUNOBLOTTING; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MOLECULAR SEQUENCE DATA; MYELIN PROTEINS; OXIDOREDUCTASES; PEPTIDE FRAGMENTS; RATS; SEQUENCE HOMOLOGY, AMINO ACID;

EID: 84862612083     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1101898     Document Type: Article

References (32)

1. Barun, B., and A. Bar-Or. 2012. Treatment of multiple sclerosis with anti-CD20 antibodies. Clin. Immunol. 142: 31-37.
2. Comabella, M., and S. J. Khoury. 2012. Immunopathogenesis of multiple sclerosis. Clin. Immunol. 142: 2-8.
3. Stadelmann, C. 2011. Multiple sclerosis as a neurodegenerative disease: pathology, mechanisms and therapeutic implications. Curr. Opin. Neurol. 24: 224-229.
4. Hu, W., and C. F. Lucchinetti. 2009. The pathological spectrum of CNS inflammatory demyelinating diseases. Semin. Immunopathol. 31: 439-453.
5. Clements, C. S., H. H. Reid, T. Beddoe, F. E. Tynan, M. A. Perugini, T. G. Johns, C. C. Bernard, and J. Rossjohn. 2003. The crystal structure of myelin oligodendrocyte glycoprotein, a key autoantigen in multiple sclerosis. Proc. Natl. Acad. Sci. USA 100: 11059-11064. (Pubitemid 37140152)
6. Komiyama, Y., S. Nakae, T. Matsuki, A. Nambu, H. Ishigame, S. Kakuta, K. Sudo, and Y. Iwakura. 2006. IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis. J. Immunol. 177: 566-573. (Pubitemid 43939170)
7. Langrish, C. L., Y. Chen, W. M. Blumenschein, J. Mattson, B. Basham, J. D. Sedgwick, T. McClanahan, R. A. Kastelein, and D. J. Cua. 2005. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J. Exp. Med. 201: 233-240. (Pubitemid 40189432)
8. Reboldi, A., C. Coisne, D. Baumjohann, F. Benvenuto, D. Bottinelli, S. Lira, A. Uccelli, A. Lanzavecchia, B. Engelhardt, and F. Sallusto. 2009. C-C chemokine receptor 6-regulated entry of TH-17 cells into the CNS through the choroid plexus is required for the initiation of EAE. Nat. Immunol. 10: 514-523.
9. Oliver, A. R., G. M. Lyon, and N. H. Ruddle. 2003. Rat and human myelin oligodendrocyte glycoproteins induce experimental autoimmune encephalomyelitis by different mechanisms in C57BL/6 mice. J. Immunol. 171: 462-468. (Pubitemid 36745321)
10. Marta, C. B., A. R. Oliver, R. A. Sweet, S. E. Pfeiffer, and N. H. Ruddle. 2005. Pathogenic myelin oligodendrocyte glycoprotein antibodies recognize glycosylated epitopes and perturb oligodendrocyte physiology. Proc. Natl. Acad. Sci. USA 102: 13992-13997. (Pubitemid 41377691)
11. Mendel, I., N. Kerlero de Rosbo, and A. Ben-Nun. 1995. A myelin oligodendrocyte glycoprotein peptide induces typical chronic experimental autoimmune encephalomyelitis in H-2b mice: fine specificity and T cell receptor V beta expression of encephalitogenic T cells. Eur. J. Immunol. 25: 1951-1959.
12. Sweenie, C. H., K. J. Mackenzie, A. Rone-Orugboh, M. Liu, and S. M. Anderton. 2007. Distinct T cell recognition of naturally processed and cryptic epitopes within the immunodominant 35-55 region of myelin oligodendrocyte glycoprotein. J. Neuroimmunol. 183: 7-16. (Pubitemid 46217774)
13. Arunachalam, B., U. T. Phan, H. J. Geuze, and P. Cresswell. 2000. Enzymatic reduction of disulfide bonds in lysosomes: characterization of a gammainterferon- inducible lysosomal thiol reductase (GILT). Proc. Natl. Acad. Sci. USA 97: 745-750. (Pubitemid 30070380)
14. Luster, A. D., R. L. Weinshank, R. Feinman, and J. V. Ravetch. 1988. Molecular and biochemical characterization of a novel gamma-interferon-inducible protein. J. Biol. Chem. 263: 12036-12043.
15. Phan, U. T., B. Arunachalam, and P. Cresswell. 2000. Gamma- interferoninducible lysosomal thiol reductase (GILT). Maturation, activity, and mechanism of action. J. Biol. Chem. 275: 25907-25914.
16. Maric, M., B. Arunachalam, U. T. Phan, C. Dong, W. S. Garrett, K. S. Cannon, C. Alfonso, L. Karlsson, R. A. Flavell, and P. Cresswell. 2001. Defective antigen processing in GILT-free mice. Science 294: 1361-1365. (Pubitemid 33063106)
17. Amor, S., N. Groome, C. Linington, M. M. Morris, K. Dornmair, M. V. Gardinier, J. M. Matthieu, and D. Baker. 1994. Identification of epitopes of myelin oligodendrocyte glycoprotein for the induction of experimental allergic encephalomyelitis in SJL and Biozzi AB/H mice. J. Immunol. 153: 4349-4356. (Pubitemid 24346829)
18. Lyons, J. A., M. San, M. P. Happ, and A. H. Cross. 1999. B cells are critical to induction of experimental allergic encephalomyelitis by protein but not by a short encephalitogenic peptide. Eur. J. Immunol. 29: 3432-3439. (Pubitemid 29527790)
19. Bansal, R., M. Kumar, K. Murray, R. S. Morrison, and S. E. Pfeiffer. 1996. Regulation of FGF receptors in the oligodendrocyte lineage. Mol. Cell. Neurosci. 7: 263-275. (Pubitemid 26187836)
20. Pfeiffer, S. E., A. E. Warrington, and R. Bansal. 1993. The oligodendrocyte and its many cellular processes. Trends Cell Biol. 3: 191-197. (Pubitemid 23156606)
21. Bottenstein, J. E., and G. H. Sato. 1979. Growth of a rat neuroblastoma cell line in serum-free supplemented medium. Proc. Natl. Acad. Sci. USA 76: 514-517. (Pubitemid 9106659)
22. Gard, A. L., and S. E. Pfeiffer. 1989. Oligodendrocyte progenitors isolated directly from developing telencephalon at a specific phenotypic stage: myelinogenic potential in a defined environment. Development 106: 119-132. (Pubitemid 19150676)
23. Menon, K., M. N. Rasband, C. M. Taylor, P. Brophy, R. Bansal, and S. E. Pfeiffer. 2003. The myelin-axolemmal complex: biochemical dissection and the role of galactosphingolipids. J. Neurochem. 87: 995-1009. (Pubitemid 37444574)
24. Marta, C. B., C. M. Taylor, T. Coetzee, T. Kim, S. Winkler, R. Bansal, and S. E. Pfeiffer. 2003. Antibody cross-linking of myelin oligodendrocyte glycoprotein leads to its rapid repartitioning into detergent-insoluble fractions, and altered protein phosphorylation and cell morphology. J. Neurosci. 23: 5461-5471. (Pubitemid 36807820)
25. Marta, C. B., M. B. Montano, C. M. Taylor, A. L. Taylor, R. Bansal, and S. E. Pfeiffer. 2005. Signaling cascades activated upon antibody cross-linking of myelin oligodendrocyte glycoprotein: potential implications for multiple sclerosis. J. Biol. Chem. 280: 8985-8993. (Pubitemid 40409590)
26. Marta, C. B., C. M. Taylor, S. Cheng, R. H. Quarles, R. Bansal, and S. E. Pfeiffer. 2004. Myelin associated glycoprotein cross-linking triggers its partitioning into lipid rafts, specific signaling events and cytoskeletal rearrangements in oligodendrocytes. Neuron Glia Biol. 1: 35-46.
27. Haque, M. A., P. Li, S. K. Jackson, H. M. Zarour, J. W. Hawes, U. T. Phan, M. Maric, P. Cresswell, and J. S. Blum. 2002. Absence of gamma-interferoninducible lysosomal thiol reductase in melanomas disrupts T cell recognition of select immunodominant epitopes. J. Exp. Med. 195: 1267-1277. (Pubitemid 34564329)
28. Slavin, A. J., J. M. Soos, O. Stuve, J. C. Patarroyo, H. L. Weiner, A. Fontana, E. K. Bikoff, and S. S. Zamvil. 2001. Requirement for endocytic antigen processing and influence of invariant chain and H-2M deficiencies in CNS autoimmunity. J. Clin. Invest. 108: 1133-1139. (Pubitemid 32995371)
29. Tompkins, S. M., J. Padilla, M. C. Dal Canto, J. P. Ting, L. Van Kaer, and S. D. Miller. 2002. De novo central nervous system processing of myelin antigen is required for the initiation of experimental autoimmune encephalomyelitis. J. Immunol. 168: 4173-4183. (Pubitemid 34298426)
30. Drayton, D. L., S. Liao, R. H. Mounzer, and N. H. Ruddle. 2006. Lymphoid organ development: from ontogeny to neogenesis. Nat. Immunol. 7: 344-353.
31. Bogunovic, B., P. Srinivasan, Y. Ueda, Y. Tomita, and M. Maric. 2010. Comparative quantitative mass spectrometry analysis of MHC class II-associated peptides reveals a role of GILT in formation of self-peptide repertoire. PLoS ONE 5: e10599.
32. Marta, C. B., R. Bansal, and S. E. Pfeiffer. 2008. Microglial Fc receptors mediate physiological changes resulting from antibody cross-linking of myelin oligodendrocyte glycoprotein. J. Neuroimmunol. 196: 35-40.